Norgine receives positive CHMP opinion recommending approval of NPJ5008 for the treatment of malignant hyperthermia

Norgine BV Germany United Kingdom Switzerland France Italy Netherlands Spain Belgium Austria

View original content:https://www.prnewswire.co.uk/news-releases/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia-302099840.html